Background A recent WHO recommendation for perennial malaria chemoprevention (PMC) encourages countries to adapt dose timing and number to local conditions. However …
C Sauboin, LA Van Bellinghen… - MDM Policy & …, 2019 - journals.sagepub.com
Background. Malaria is a major public health burden in sub-Saharan Africa. This study estimated the cost-effectiveness and budget impact of adding four-dose malaria vaccination …
Abstract The World Health Organization has selected Malawi as one of three sites to pilot the roll-out of RTS, S/AS01 in phase 4 trials. As policy discussions for the expanded use of RTS …
Background: The RTS, S/AS01 E malaria vaccine is being assessed in Malawi, Ghana and Kenya as part of a large-scale pilot implementation programme. Even if impactful, its …
Abstract Background The RTS, S/AS01 malaria vaccine is currently being evaluated in a cluster-randomized pilot implementation programme in three African countries. This study …
M Golumbeanu, GJ Yang, F Camponovo… - Infectious Diseases of …, 2022 - mednexus.org
Background: Substantial research is underway to develop next-generation interventions that address current malaria control challenges. As there is limited testing in their early …
Mathematical models provide the essential basis of rational research and development strategies in malaria, informing the choice of which technologies to target, which deployment …
F Camponovo, CF Ockenhouse, C Lee… - BMC infectious …, 2019 - Springer
Background The only licensed malaria vaccine, RTS, S/AS01, has been developed for morbidity-control in young children. The potential impact on transmission of deploying such …
J Clemens, V Moorthy - New England Journal of Medicine, 2016 - Mass Medical Soc
In 2015, an estimated 438,000 people died from malaria. 1 The overwhelming majority of these deaths occurred in young African children who were infected with Plasmodium …